PhD Shannon Morgan-Pelosi, Xingping Zhao, Jiezhi Ma, Livia Xhindoli, Gabriella Schivardi, Luigi Antonio De Vitis, Benedetto Emmanuel, Guillot Giulia, Maria Teresa Pappalettera, Alessia Achilarre, Simone Aloisi, Annalisa Bruni, Garbi Giovanni, Vanna Damiano Aletti, Angelo Zanagnolo, Nicoletta Maggioni, Colombo Ilaria, Francesco Multinu Betella
{"title":"Prospective","authors":"PhD Shannon Morgan-Pelosi, Xingping Zhao, Jiezhi Ma, Livia Xhindoli, Gabriella Schivardi, Luigi Antonio De Vitis, Benedetto Emmanuel, Guillot Giulia, Maria Teresa Pappalettera, Alessia Achilarre, Simone Aloisi, Annalisa Bruni, Garbi Giovanni, Vanna Damiano Aletti, Angelo Zanagnolo, Nicoletta Maggioni, Colombo Ilaria, Francesco Multinu Betella","doi":"10.2307/j.ctt6wrbt1.4","DOIUrl":null,"url":null,"abstract":". Clinical information and trans-vaginal ultrasound measurements were also obtained. Univariate logistic regression and receiver operating characteristic curve analysis were performed to assess the risk factors and diagnostic efficacy of DNA methylation detection. Results Age, body mass index (BMI) (cid:1) 25 kg/m 2 , endometrial thickness (cid:1) 11 mm, CDO1 D Ct £ 8.4, CELF4 D Ct £ 8.8, and combined gene methylation showed significant associations with endometrial cancer in young women (p < 0.05). The highest diagnostic accuracy (AUC = 0.90) for endometrial cancer was achieved with CDO1/CELF4 methylation testing. Sensitivity and specificity were 91.7% and 88.8%, respectively. Combining transvaginal ultrasound with DNA methylation testing improved sensitivity to 95.8% but decreased specificity to 68.0%. Conclusion DNA methylation detection in cervical cells provides enhanced accuracy for endometrial cancer diagnosis in reproductive-aged women with AUB. The combination of CDO1 and CELF4 methylation testing with transvaginal ultrasound improves sensitivity, highlighting its potential as a valuable screening approach.","PeriodicalId":283502,"journal":{"name":"Écoréfugiés au pays des bayous. Les Indiens houmas face au golfe du Mexique","volume":"119 17","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"279","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Écoréfugiés au pays des bayous. Les Indiens houmas face au golfe du Mexique","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2307/j.ctt6wrbt1.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 279
Abstract
. Clinical information and trans-vaginal ultrasound measurements were also obtained. Univariate logistic regression and receiver operating characteristic curve analysis were performed to assess the risk factors and diagnostic efficacy of DNA methylation detection. Results Age, body mass index (BMI) (cid:1) 25 kg/m 2 , endometrial thickness (cid:1) 11 mm, CDO1 D Ct £ 8.4, CELF4 D Ct £ 8.8, and combined gene methylation showed significant associations with endometrial cancer in young women (p < 0.05). The highest diagnostic accuracy (AUC = 0.90) for endometrial cancer was achieved with CDO1/CELF4 methylation testing. Sensitivity and specificity were 91.7% and 88.8%, respectively. Combining transvaginal ultrasound with DNA methylation testing improved sensitivity to 95.8% but decreased specificity to 68.0%. Conclusion DNA methylation detection in cervical cells provides enhanced accuracy for endometrial cancer diagnosis in reproductive-aged women with AUB. The combination of CDO1 and CELF4 methylation testing with transvaginal ultrasound improves sensitivity, highlighting its potential as a valuable screening approach.